Panretin (Alitretinoin) Gel
Company:  Ligand Pharmaceuticals
Application No.:  20-886
Approval Date: 2/2/1999

• Approval Letter (734 KB)

• Medical Review(s)

  Part 1 (2.4 MB)	Part 5 (2.3 MB)	Part 9 (2.8 MB)
  Part 2 (2.3 MB)	Part 6 (2.8 MB)	Part 10 (2.9 MB)
  Part 3 (2.9 MB)	Part 7 (2.7 MB)	Part 11 (2.8 MB)
  Part 4 (2.7 MB)	Part 8 (2.5 MB)	Part 12 (3 MB)

• Chemistry Review(s) (1.3 MB)

• Pharmacology Review(s)
  Part 1 (2.3 MB)
  Part 2 (2 MB)

• Statistical Review(s)
  Part 1 (2.3 MB)
  Part 2 (1.9 MB)
  Part 3 (2.6 MB)
  Part 4 (2.2 MB)

• Clinical Pharmacology Biopharmaceutics Review(s)
  Part 1 (1.5 MB)
  Part 2 (1.9 MB)
  Part 3 (2.5 MB)
  Part 4 (2.8 MB)

• Administrative Document(s)/Correspondence (2.3 MB)

Back to Drug Approval Page

PDF requires the free Adobe Acrobat Reader

Date created: March 30, 2001; last update: July 5, 2005

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research